(1r)-1-(5-Bromothiophen-2-yl)ethan-1-ol, 95%, 250mg

Matraces aforados DURAN® clase A, USP<31>, 100 ml, 14/23, 2 Unidad(es)

4-Bromoquinolin-3-amine, 97%, 100mg

(3-Ethoxycarbonyl-5-nitrophenyl)boronic acid, 95.0%, 25g

2-Formyl-3-(4-fluorophenyl)-1-N-methyl indole, 98.0%, 1g

2,4-Dichloropteridine, 95.0%, 250mg

1,1,4,4,7,7,10,10-Octamethyl-2,3,4,7,8,9,10,12-octahydro-1H-dibenzo[b,h]fluorene, 95.0%, 5g

N,N-Diethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine, 95.0%, 100mg

(6R,7R)-7-Amino-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 95.0%, 25g

2-(4-ethoxyphenyl)-6-[6-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazol-2-yl]-1H-1,3-benzodiazole, 98%, 250mg

2-(5-Fluoro-2-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 5g

5-Nitro-1H-indole-2-carboxylic Acid>97.0%(GC)(T)1g

1,3-Bis[2-(7-oxabicyclo[4.1.0]heptan-3-yl)ethyl]-1,1,3,3-tetramethyldisiloxane>95.0%(GC)5g